QIAGEN beats outlook for fourth quarter and full-year 2020, reaffirms expectations for further growth in 2021

Venlo, the Netherlands, February 9, 2021 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced strong results of operations for the fourth quarter and full-year 2020, exceeding the goals for net sales and adjusted earnings per share. Net sales in the fourth quarter of 2020 rose 38% (+36% at constant exchange rates, CER) to... Read more

Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results Feb 08, 2021 4:01 PM EST AUSTIN, Texas, Feb. 8, 2021 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced results for its fourth quarter and full-year ended December 31,... Read more

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of... Read more

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of... Read more

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of... Read more

Thermo Fisher Scientific Analytical Instruments Receive Prominent Industry Awards

Thermo Fisher Scientific Analytical Instruments Receive Prominent Industry Awards SAN JOSE, Calif., Feb. 4, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced that several of its analytical instruments and solutions have been recognized through multiple respected industry awards. These award-winning analytical solutions support scientists across many sectors including pharmaceuticals,... Read more

Bruker Announces Date and Time of Fourth Quarter 2020 Earnings Release and Webcast

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2020 financial results on Tuesday, February 16, 2021, before the market opens. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to... Read more

Brooks Automation Reports Results of First Quarter of Fiscal 2021, Ended December 31, 2020, and Announces Quarterly Cash Dividend

Brooks Automation Reports Results of First Quarter of Fiscal 2021, Ended December 31, 2020, and Announces Quarterly Cash Dividend Strong Revenue Growth and Margin Expansion Year Over Year In Both Life Sciences and Semiconductor Solutions CHELMSFORD, Mass., Feb. 2, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today reported financial results for the first fiscal quarter... Read more